1. Home
  2. SUNS vs RCEL Comparison

SUNS vs RCEL Comparison

Compare SUNS & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUNS
  • RCEL
  • Stock Information
  • Founded
  • SUNS 2023
  • RCEL N/A
  • Country
  • SUNS United States
  • RCEL United States
  • Employees
  • SUNS N/A
  • RCEL N/A
  • Industry
  • SUNS Real Estate Investment Trusts
  • RCEL Medical/Dental Instruments
  • Sector
  • SUNS Real Estate
  • RCEL Health Care
  • Exchange
  • SUNS Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • SUNS 142.3M
  • RCEL 152.1M
  • IPO Year
  • SUNS N/A
  • RCEL N/A
  • Fundamental
  • Price
  • SUNS $10.57
  • RCEL $5.63
  • Analyst Decision
  • SUNS Strong Buy
  • RCEL Strong Buy
  • Analyst Count
  • SUNS 3
  • RCEL 4
  • Target Price
  • SUNS $13.58
  • RCEL $14.75
  • AVG Volume (30 Days)
  • SUNS 61.1K
  • RCEL 423.6K
  • Earning Date
  • SUNS 08-07-2025
  • RCEL 08-07-2025
  • Dividend Yield
  • SUNS 11.35%
  • RCEL N/A
  • EPS Growth
  • SUNS N/A
  • RCEL N/A
  • EPS
  • SUNS 1.04
  • RCEL N/A
  • Revenue
  • SUNS $16,359,932.00
  • RCEL $74,884,000.00
  • Revenue This Year
  • SUNS $185.50
  • RCEL $57.16
  • Revenue Next Year
  • SUNS $64.44
  • RCEL $36.69
  • P/E Ratio
  • SUNS $10.13
  • RCEL N/A
  • Revenue Growth
  • SUNS 1342.10
  • RCEL 38.32
  • 52 Week Low
  • SUNS $7.80
  • RCEL $3.60
  • 52 Week High
  • SUNS $15.74
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • SUNS N/A
  • RCEL 52.24
  • Support Level
  • SUNS N/A
  • RCEL $5.53
  • Resistance Level
  • SUNS N/A
  • RCEL $6.00
  • Average True Range (ATR)
  • SUNS 0.00
  • RCEL 0.41
  • MACD
  • SUNS 0.00
  • RCEL 0.06
  • Stochastic Oscillator
  • SUNS 0.00
  • RCEL 79.61

About SUNS Sunrise Realty Trust Inc. Common Stock

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: